Back to Search
ZHENYANG JIANG, M.D.
M.D.
Internal Medicine Physician
NPI: 1649619164IndividualAccepts Medicare
Education
OTHER
Class of 2003
Research & Publications (20)
Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas.
PMID 18412154·Cancer·2008
4-observational
Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas.
PMID 18765551·Clin Cancer Res·2008
8-other
Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.
PMID 16814207·Lancet Oncol·2006
8-other
Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.
PMID 15799971·J Biol Chem·2005
7-preclinical
Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
PMID 15842047·Am J Clin Pathol·2005
8-other
Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
PMID 15330799·Histopathology·2004
8-other
Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.
PMID 15505533·Adv Anat Pathol·2004
6-review
Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
PMID 15323145·Am J Clin Pathol·2004
6-review
P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens.
PMID 14750247·Am J Clin Pathol·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 211 PARK ST
ATTLEBORO, MA 02703 - Phone
- (508) 222-5200
Locations (5)
Quick Facts
- NPI
- 1649619164
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 5
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile